Galectin-3 secreted by triple-negative breast cancer cells regulates T cell function
Triple-negative breast cancer (TNBC) is an aggressive subtype that accounts for 10-15 % of breast cancer. Current treatment of high-risk early-stage TNBC includes neoadjuvant chemo-immune therapy. However, the substantial variation in immune response prompts an urgent need for new immune-targeting a...
Saved in:
Main Authors: | Annat Raiter, Yael Barhum, Julia Lipovetsky, Chen Menachem, Sharona Elgavish, Shmuel Ruppo, Yehudit Birger, Shai Izraeli, Orna Steinberg-Shemer, Rinat Yerushalmi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-02-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558624001581 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative analysis of galectin-1, galectin-3, and galectin-8 signatures in normal and choriocarcinoma trophoblast cell lines
by: Jovanović Krivokuća Milica, et al.
Published: (2024-01-01) -
Editorial: Galectins and hormones in health and disease
by: María F. Troncoso, et al.
Published: (2025-02-01) -
PRDX2 induces tumor immune evasion by modulating the HDAC3-Galectin-9 axis in lung adenocarcinoma cells
by: Yunjia Dong, et al.
Published: (2025-01-01) -
Plasma galectin-3 can be considered as a non-invasive marker to predict the prognosis of ACLF patients with new typing
by: Li Bai, et al.
Published: (2025-01-01) -
Metformin dosage and galectin-3 levels: insights from PCOS patients preparing for IVF
by: Valentina N. Nikolić, et al.
Published: (2025-01-01)